Pharming Group NV (PHARM) — Cash Flow Quality Index
Pharming Group NV (PHARM) has a Cash Flow Quality Index of 2.51x as of September 2025. Operating cash flow of €32.03 Million exceeds net income of €12.76 Million, indicating high earnings quality where cash backs reported profits. Explore Pharming Group NV (PHARM) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Pharming Group NV Cash Flow Quality Index (2017–2022)
Historical Cash Flow Quality Index for Pharming Group NV across 6 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see PHARM cash flow conversion.
Annual Cash Flow Quality Index for Pharming Group NV (2017–2022)
Year-by-year earnings quality comparison for Pharming Group NV.
| Year | Quality Index | Operating CF (EUR) | Net Income | YoY Change |
|---|---|---|---|---|
| 2022 | 1.53x | €22.90 Million | €14.99 Million | ▼ -6.8% |
| 2021 | 1.64x | €36.13 Million | €22.03 Million | ▼ -14.5% |
| 2020 | 1.92x | €90.98 Million | €47.47 Million | ▲ +75.4% |
| 2019 | 1.09x | €74.56 Million | €68.23 Million | ▲ +2.8% |
| 2018 | 1.06x | €46.19 Million | €43.46 Million | ▼ -39.1% |
| 2017 | 1.74x | €45.84 Million | €26.29 Million | — |